Philip Morris Korea will launch a next-generation e-cigarette, which is less harmful and equipped with a new type of tobacco heating system, the IQOS ILUMA, next month.
Paik Young-jae, managing director of Philip Morris Korea, stressed that their new products emit 95 percent less harmful substances than a normal cigarette because they heat tobacco instead of burning it.
The new product has no blades and does not require cleaning.
As the device’s Smartcore induction system does not burn tobacco but heats it inside to offer a consistent, quality smoking experience, there is no residue after use.
The new stick-type tobacco item, the Terra Smartcore Stick, with IQOS ILUMA, functions automatically when used.
According to Jacek Olczak, CEO of Philip Morris International, they are expanding their portfolio and seeking innovative items to realize their 'smoke-free' future vision,"
The IQOS ILUMA series comes in two types: the IQOS ILUMA PRIME, which features luxurious monotone aluminum material and it comes in four different colors, and the IQOS ILUMA, which adopts a holder made with cutting-edge technology and it comes in five colors. Both products can be used twice consecutively after charging them fully one time.
IQOS ILUMA products will be available at 15 directly managed stores as well as convenience stores in South Korea starting from Nov. 10.
As of July 2022, Philip Morris International sells non-combustible e-cigarette products in 70 nations. According to the corporation, its IQOS products are used by more than 19 million individuals worldwide.


Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Why have so few atrocities ever been recognised as genocide?
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Heritage, desire and diplomacy: why China still values scotch whisky
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Asian Stocks Rise on AI Optimism and Iran Peace Talk Hopes
John Ternus Signals Apple’s Future with Product-First AI Strategy
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Disaster or digital spectacle? The dangers of using floods to create social media content
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Why a ‘rip-off’ degree might be worth the money after all – research study 



